Digital Pharma: iPhone and iPad app update
July 15, 2011Medical Communications, Sales and Marketing Blackberry, Digital Pharma blog, ipad, iphone, mobile
How many iPads has Boehringer Ingelheim ordered for its sales force in Turkey? Do Novartis’ investors really want their annual …
Lophius Biosciences expands management team
July 15, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
German biotech Lophius Biosciences has made six senior management appointments ahead of a planned 2012 market entry move. The Regensburg-based …
Reynolds-MacKenzie joins Open Health
July 15, 2011Medical Communications medical communications agency, medical communications news
Specialist health agency Reynolds-MacKenzie has become the latest recruit to the Open Health stable, bolstering the new communications group’s PR …
The changing fortunes of NICE and health secretaries
July 15, 2011Sales and Marketing NICE
You might not have noticed, but the government has performed a major U-turn. No, I don’t mean the NHS reform …
UK pricing reform derailed
July 15, 2011Sales and Marketing NICE, PPRS, value-based pricing
Plans to revolutionise the pricing of medicines in the UK look to be another casualty in the Department of Health’s …
Digital Pharma: Facebook warning for UK doctors
July 14, 2011Medical Communications BMA, Digital Pharma blog, doctors, nurses, social media
UK doctors have been told not to accept patients as Facebook friends in order to maintain professional boundaries. The BMA’s …
European approval for BMS skin cancer vaccine
July 14, 2011Sales and Marketing BMS, Yervoy, ipilimumab
Bristol-Myers Squibb’s skin cancer vaccine Yervoy has been approved in Europe after showing survival benefits in one of the most …
France cleans up regulation – and restricts pharma role
July 14, 2011Research and Development, Sales and Marketing France, Mediator, Servier, pharmacovigilance, research and development news
France has unveiled sweeping changes to how it regulates prescription medicines following the scandal surrounding Servier’s Médiator. Health minister Xavier …
Spain’s austerity sees pharma market shrink by €2 billion
July 14, 2011Sales and Marketing Spain, healthcare costs
Spain’s pharma industry has hit out against the drastic budget cuts the government introduced last year, saying they’ve led to …
Market access and the new consortia
July 14, 2011Sales and Marketing GP consortia, NHS reform, market access
The National Health Service in England is undergoing massive structural and financial upheaval, and pharma marketers will be rightly concerned …
Paul Barrow joins CiToxLAB
July 14, 2011Research and Development appointment, research and development
French CRO CiToxLAB has appointed Paul Barrow as director of scientific projects and client consulting. He joins the Evreux-based company, …
What now for GP consortia?
July 13, 2011Sales and Marketing GP consortia, NHS reforms
David Cameron unveiled major changes to the direction of the health reforms on 8 June – and in doing so, …
Sanofi eyes phase III move for sarilumab in rheumatoid arthritis
July 13, 2011Research and Development Regeneron, Sanofi, ankylosing spondylitis, research and development news, rheumatoid arthritis, sarilumab
Sanofi is poised to move sarilumab into phase III trials for rheumatoid arthritis after the monoclonal antibody showed positive results …
Pharma regulators consult on drug development initiatives
July 13, 2011Research and Development Companion Diagnostics, EMA, FDA, Pharmacogenomics, biomarkers, research and development news
Pharma regulators in the US and Europe have put out separate consultations on issues affecting how medicines are developed. The …
Amgen collaborates on cancer antibody research
July 13, 2011Research and Development Amgen, Cancer, TGF-beta monoclonal antibody, research and development news
Amgen has teamed up with German biotech Micromet to develop tumour-destroying antibodies in a two-year deal that could net Micromet …
Clavis Pharma appoints Nicholas Adams
July 13, 2011Research and Development appointment, research and development
Norwegian cancer drug development company Clavis Pharma has appointed Nicholas Adams as chief business officer. He has more than 23 …
Kantar Health Launches Global Health and Wellness Quarterly Update
July 12, 2011Sales and Marketing Kantar Health, depression, emerging markets, information, newsletter, work productivity
The inaugural issue of Kantar Health’s Global Health and Wellness Update is now available. This is a quarterly newsletter sharing …
EMA widens safety review of Sanofi’s Multaq
July 12, 2011Sales and Marketing Multaq, Sanofi
European regulators are to extend their assessment of the risks associated with Sanofi’s atrial fibrillation (AF) medicine Multaq to take …
Cellectis appoints Dr Andrew Scharenberg
July 12, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
Paris-based genome engineering specialist Cellectis Therapeutics has appointed Dr Andrew Scharenberg as chief scientific officer. He is an attending physician …
EMA plans adverse event reports for the public
July 12, 2011Research and Development, Sales and Marketing EMA, adverse events, patient information
The EMA will start producing monthly adverse event reports for the public as part of its plans to open up …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
